Upgrade to SI Premium - Free Trial

TD Cowen Boston Scientific (BSX): 'We Maintain Our Constructive 2027-Based View'

September 17, 2026 9:39 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments